Abstract
ABSTRACT
Three possibilities exist, in principle, to apply medication by inhalation:
(1) Inhalation from Pressurized Metered Dose Inhalers (2) Direct Inhalation of Dry Powder (3) Inhalation of Nebulized Aqueous Solutions
Chlorofluorocarbons that are necessary for pressurized metered dose inhalers have unwanted environmental properties. Therefore, alternative gases are being developed (HFA-134a and HFA 227) on the premise that pressurized metered dose aerosols in airways therapy have distinct advantages which are reflected in the high acceptance and application of these MDIs worldwide.
Dry powder inhalation requires sophisticated devices to provide for exact dosing.
For nebulizers the major problem was their size and consequently their restricted use. Multi-dose pocket-size systems are on the market for (1) and (2). For nebulization such a system is currently being introduced.
A critical comparison of benefits and disadvantages of the existing drug delivery systems to the airways leads to the conclusion that all three modes will remain essential to cover the therapeutic needs for a wide variety of drugs and patient populations.
Get full access to this article
View all access options for this article.